TM-Logo-Navy.png
Novotech Appoints Commercial and Clinical Life Sciences Specialist to Head Up Global Drug Development Consulting Team
02 mai 2024 17h00 HE | Novotech
Novotech CRO appoints Scott Schliebner as Vice President and Global Head, Drug Development Consulting (DDC).
TM-logo-no-tag-navy-brand-rec-white 1.jpg
Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs Across 25 Regions
08 janv. 2024 07h38 HE | Novotech
Novotech announced today that it will have the largest ever presence at the J.P.Morgan Healthcare Conference in San Francisco, CA, USA, January 8-11, 2024.
TM-logo-no-tag-navy-brand-rec-white 1.jpg
Early-Stage Biotech Investments Were Down 40% in 2023: Novotech Whitepaper
29 déc. 2023 01h54 HE | Novotech
Novotech today published the Navigating the Biotech Landscape whitepaper examining the significant financial shifts that affected the biotech industry.
NVT Logo (4).jpg
Novotech Opens ChinaTrials 15 Conference with Workshop on how Biotechs can Accelerate Global Trials
07 nov. 2023 02h24 HE | Novotech
Novotech CRO opens the ChinaTrials 15 conference in Shanghai, China on accelerating drug development.
NVT Logo (4).jpg
Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award
10 oct. 2023 03h59 HE | Novotech
Novotech has been selected as the CRO Company of the Year 2023 by growth advisory and opportunity analytics firm Frost & Sullivan.
NVT Logo (4).jpg
Novotech Awarded Cell & Gene Therapy CRO Excellence 2023
19 sept. 2023 03h56 HE | Novotech
SINGAPORE, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has just been awarded for the second consecutive year the Best...